Home › Funds › Genus Capital Management Inc. › ABBV

Genus Capital Management Inc. position in ABBV

ABBVIE INC · Health Care

Genus Capital Management Inc. reported holding 71,654 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$18.7M, representing 1.87% of its reported portfolio and ranking #9 among its reported holdings. Genus Capital Management Inc. has disclosed ABBV holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)71.65K sh
Reported value held$18.74M
Portfolio Weight1.87%
First reportedQ1 2024
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Genus Capital Management Inc.'s ABBV position evolved

Genus Capital Management Inc. first disclosed a stake in ABBV in Q1 2024 at 13,700 shares (US$2.5M). The position peaked in Q3 2026 at 71,654 shares, worth US$18.7M. Across 11 filings, Genus Capital Management Inc. increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 71,654 shares valued at US$18.7M — an increase of 44,986 shares quarter over quarter.. Notable position changes include a 152% increase in Q2 2024 (shares rose 16% over the following quarter), a 662% increase in Q2 2026 (shares rose 5% over the following quarter), a 169% increase in Q3 2026 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 13.70K $2.49M New
Q2 2024 34.53K $5.92M Add
Q3 2024 60.05K $11.86M Add
Q4 2024 38.78K $6.89M Reduce
Q1 2025 68.77K $14.41M Add
Q2 2025 27.37K $5.08M Reduce
Q3 2025 45.59K $10.55M Add
Q4 2025 63.64K $14.54M Add
Q1 2026 3.50K $760.78K Reduce
Q2 2026 26.67K $6.71M Add
Q3 2026 71.65K $18.74M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Genus Capital Management Inc. held ABBV?

Genus Capital Management Inc. has disclosed ABBV holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Genus Capital Management Inc.'s current position in ABBV?

As of Q3 2026, Genus Capital Management Inc. holds 71.65K shares of ABBV (ABBVIE INC), valued at $18.74M, representing 1.87% of its reported portfolio and ranking #9.

Has Genus Capital Management Inc. been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Genus Capital Management Inc. increased its position in ABBV. The position peaked in Q3 2026 at 71.65K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.